Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase. (Q51799222)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Shunji Tomatsu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Adriana M Montaño

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Monica Gutierrez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Jeffrey H Grubb

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Vu Chi Dung

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Amiko Ohashi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Tatsuo Nishioka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Masamichi Yamada

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Mana Yamada

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Yasuhiro Tosaka

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Georgeta G Trandafirescu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Tadao Orii

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

2 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

69-78

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

The histological and ultrastructural features of the epiphyseal plate in Morquio type A syndrome (mucopolysaccharidosis type IVA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Expression, purification and characterization of recombinant human N-acetylgalactosamine-6-sulphatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

N-Acetylgalactosamine-6-Sulfate Sulfatase in Human Placenta: Purification and Characteristics1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

The biogenesis of lysosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Lessons learned from the development of enzyme therapy for Gaucher disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Clinical features of and recent advances in therapy for Fabry disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme-replacement therapy in mucopolysaccharidosis I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme replacement therapy for murine mucopolysaccharidosis type VII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme replacement therapy in Mucopolysaccharidosis VI: evidence for immune responses and altered efficacy of treatment in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Efficient selection for high-expression transfectants with a novel eukaryotic vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Review of the folin phenol protein quantitation method of lowry, rosebrough, farr and randall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Various cells retrovirally transduced with N-acetylgalactosoamine-6-sulfate sulfatase correct Morquio skin fibroblasts in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme replacement in a canine model of Hurler syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Biodistribution, kinetics, and efficacy of highly phosphorylated and non-phosphorylated beta-glucuronidase in the murine model of mucopolysaccharidosis VII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Short-term enzyme replacement in the murine model of Sanfilippo syndrome type B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enzyme replacement therapy in a feline model of MPS VI: modification of enzyme structure and dose frequency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

The human SUMF1 gene, required for posttranslational sulfatase modification, defines a new gene family which is conserved from pro- to eukaryotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.01.004

10.1016/J.YMGME.2007.01.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17336563%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference